Filter
5488
Filtered Results: 5488
Text search:
drug
development
Featured
Recommendations
474
New Publications
1477
Language
Document type
No document type
3371
Studies & Reports
856
Guidelines
658
Manuals
225
Strategic & Response Plan
167
Fact sheets
76
Training Material
73
Situation Updates
20
Infographics
14
Resource Platforms
10
Brochures
8
Online Courses
7
Dashboards/Maps
1
App
1
Videos
1
Countries / Regions
India
313
Global
190
Kenya
175
South Africa
133
Ethiopia
130
Uganda
126
Nigeria
117
Western and Central Europe
110
Tanzania
102
Nepal
101
Sierra Leone
92
Liberia
89
Zambia
87
Malawi
85
Myanmar / Burma
80
Latin America and the Carribbean
74
Ghana
73
Africa
72
Bangladesh
71
Rwanda
65
Ukraine
57
Eastern Europe
57
Philippines
52
Namibia
52
Zimbabwe
44
Asia
41
South–East Asia Region
40
Cambodia
39
Russia
38
Lesotho
37
Indonesia
32
Botswana
29
Congo, Democratic Republic of
28
Mozambique
26
Syria
23
Eswatini/ Swaziland
23
Senegal
21
Burkina Faso
20
Colombia
19
Germany
19
Brazil
17
South Sudan
17
Cameroon
16
East and Southern Africa
16
USA
15
West and Central Africa
15
Haiti
14
Middle East and North Africa
14
Tajikistan
13
Albania
12
Venezuela
12
Pakistan
11
Thailand
10
China
10
Guinea
10
Afghanistan
9
Eastern Europe and Central Asia
9
Vietnam
9
Georgia
9
Argentina
8
Sudan
8
Armenia
7
Paraguay
7
Moldova
7
Mexico
6
Laos
6
Western Pacific Region
6
North America
6
Yemen
6
North Macedonia
5
Benin
5
Peru
5
Lebanon
5
Sri Lanka
5
Central African Republic
5
Iraq
5
El Salvador
4
Jordan
4
Jamaica
4
United Kingdom
4
Bhutan
4
Somalia
4
Madagascar
4
Timor Leste/ East Timor
3
Turkey
3
Iran
3
Fiji
3
Kyrgyzstan
3
Côte d’Ivoire / Ivory Coast
3
Bolivia
3
Papua New Guinea
3
Palestine
3
Mali
3
Angola
3
Libya
3
Serbia
2
Kazakhstan
2
Chile
2
Canada
2
Estonia
2
Uzbekistan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Saudi Arabia
2
France
2
Portugal
2
Spain
2
Belarus
2
Southern Africa
2
Poland
2
Honduras
2
Ecuador
2
North Korea
1
Switzerland
1
Australia
1
Gambia
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Nicaragua
1
Egypt
1
Romania
1
Greece
1
Chad
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2139
Clinical Guidelines
487
Public Health
276
Women & Child Health
214
Key Resources
155
Capacity Building
77
Pharmacy & Technologies
62
Annual Report MEDBOX
1
Toolboxes
HIV
620
Mental Health
549
TB
524
AMR
287
NTDs
238
COVID-19
207
Pharmacy
161
NCDs
117
Caregiver
108
Rapid Response
91
Ebola & Marburg
81
Planetary Health
78
Refugee
70
Disability
65
Global Health Education
61
Conflict
58
Health Financing Toolbox
50
Polio
22
Natural Hazards
21
Specific Hazards
16
Cholera
16
Zika
16
Social Ethics
14
Malaria
12
The Rwandan Ministry of Health recognizes the threat that Non-Communicable Diseases (NCDs) pose to health and development in Rwanda and in 2009 articulates strategies to respond to them in the Health Sector Strategic Plan 2012 - 2018 (HSSP3). Among other things, the plan calls for a national prevale...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
Germany has become a visible actor in global health in the past 10 years. In this Series paper, we describe how this development complements a broad change in perspective in German foreign policy.
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
The focus of the current quarterly edition of Eurohealth (from the European Observatory on Health Systems and Policies) is Antimicrobial Resistance (AMR) and contains the following articles:
• Strengthening implementation of AMR national action plans
• Fostering clinical developmen...
The Global Programme on Tuberculosis & Lung Health of the World Health Organization (WHO/GTB) is now combining all current recommendations into one overall set of consolidated guidelines on TB. The guidelines contain recommendations pertaining to all areas related to the programmatic management of T...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention and care. It promotes discussion by comparing and analysing the extent to which selected international...
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three ...
Rwanda’s fourth health sector strategic plan (HSSP4) is meant to provide the health sector with a Strategic Plan that will highlight its commitments and priorities for the coming 6 years. It will be fully integrated in the overall economic development plan of the Government. HSSP4 will fulfill the...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
This publication is intended for professionals training or practicing in mental health and not for the general public. The opinions expressed are those of the authors and do not necessarily represent the views of the Editor or IACAPAP. This publication seeks to describe the best treatments and pract...
The Ethiopian Hospital Services Transformation Guidelines (EHSTG) build on and expand the Ethiopian Hospital Reform Implementation Guidelines (EHRIG) and are consistent with the Health Sector Transformation Plan (HSTP). The EHSTG, which is consistent with the national focu...
The Report describes the evaluation of WHO's contribution to the Maternal Health Program in South-East Asia Region. This was an independent evaluation conducted in 2015 by Amaltas, a Delhi based organization. The evaluation highlights the progress in five countries, namely Bangladesh, Indonesia, Mya...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
